CML announced that, further to the announcement on 2 October 2023, Dr Nathan Zommer has now been appointed to the board of the Company in a non-executive capacity, effective from 1 January 2024, following completion of the normal regulatory due diligence checks.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
345 GBX | -1.43% |
|
-1.43% | -7.75% |
26/03 | CML Microsystems expects revenue growth despite weak trading | AN |
2023 | CML Appoints Dr Nathan Zommer to the Board as Non-Executive, Effective from 1 January 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.75% | 70.5M | |
+138.50% | 2,903B | |
+58.52% | 753B | |
+42.64% | 741B | |
+8.72% | 259B | |
+38.86% | 224B | |
+13.71% | 177B | |
+101.04% | 157B | |
-39.16% | 130B | |
+57.60% | 111B |
- Stock Market
- Equities
- CML Stock
- News CML Microsystems plc
- CML Appoints Dr Nathan Zommer to the Board as Non-Executive, Effective from 1 January 2024